NCT05728203 is a clinical trial in Hearing Disorders, sponsored by Assiut University.

Who is sponsoring NCT05728203?

NCT05728203 is sponsored by Assiut University.

What condition does NCT05728203 study?

NCT05728203 studies Hearing Disorders.

Is NCT05728203 still recruiting?

NCT05728203 is currently status unknown. Last updated 29 March 2023.

Last reviewed 2023-03-29 · How we verify

NCT05728203

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Audiologic Assessment of Call Center Operators

Status unknown Last updated 29 March 2023

What this trial tests

trial in Hearing Disorders in 119 participants. Status unknown.

Timeline

1 June 2023

Primary endpoint
1 September 2025

1 November 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	119
Start date	1 June 2023
Primary completion	1 September 2025
Estimated completion	1 November 2025

Conditions studied

Hearing Disorders — all drugs for Hearing Disorders →

Sponsor

Assiut University

Who can join

Adults 18 to 50, any sex, with Hearing Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. Early detection of hearing affection in call center operators 2. Study the effect of this type of noise on the auditory brainstem response.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hearing Disorders

Currently open trials in the same condition.

NCT06303180 — NIDCD Otolaryngology Clinical Protocol Biospecimen Bank · recruiting
NCT05936034 — Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Sa · NA · recruiting
NCT06164483 — Auditory Functions in Patients With Multiple Sclerosis · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05728203 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 29 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05728203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing